Serum levels of interleukin-18 in splenectomized and nonsplenectomized thalassemic patients: Preliminary considerations

Acta Haematologica

Volumn 110, Issue 1, 2003, Pages 45-47

  Gangemi, S ^a   Merendino, R A ^a   Meo, A ^a   Minciullo, P L ^a   Briuglia, S ^a   Merlino, M V ^a   Rigoli, L ^a   Tomasello, C ^a   Salpietro, C D ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGE; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE INDUCTION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SPLENECTOMY; STATISTICAL SIGNIFICANCE; THALASSEMIA MAJOR;

BETA-THALASSEMIA; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-18; SPLENECTOMY;

EID: 0141676419     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072416     Document Type: Article

References (21)

1. Eldor A, Rachmilewitz EA: The hypercoagulable state in thalassemia. Blood 2002;99:36-43.
2. Akbar AN, Fitzgerald-Bocarsly PA, de Sousa M, Giardina PJ, Hilgartner MW, Grady RW: Decreased natural killer activity in thalassemia major: A possible consequence of iron overload. J Immunol 1986;136:1635-1640.
3. Speer CP, Gahr M, Schuff-Werner P, Schroter W: Immunologic evaluation of children with homozygous beta-thalassemia treated with desferrioxamine. Acta Haematol 1990;83:76-81.
4. Pardalos G, Kanakoudi-Tsakalidis F, Malaka-Zafiriu M, Tsantali H, Athanasiou-Metaxa M, Kallinikos G, Papaevangelou G: Iron-related disturbances of cell-mediated immunity in multitransfused children with thalassemia major. Clin Exp Immunol 1987;68:138-145.
5. Li K, Li CK, Wong RP, Wong A, Shing MM, Chik KW, Yuen PM: Transfusion-related immunomodulation in Chinese children with thalassemia. Vox Sang 1997;73:167-173.
6. Clauvel JP, Brouet JC, Maisonneuve P, Perol Y, Sultan Y: Lymphocyte subpopulations in hemophilic patients. Presse Méd 1984;13:19-22.
7. Ozturk O, Yaylim I, Aydin M, Yilmaz H, Agachan B, Demiralp E, Isbir T: Increased plasma levels of interleukin-6 and interleukin-8 in beta-thalassemia major. Haematologia (Budapest) 2001;31:237-244.
8. Uguccioni M, Meliconi R, Nesci S, Lucarelli G, Ceska M, Gasbarrini G, Facchini A: Elevated interleukin-8 serum concentrations in beta-thalassemia and graft-versus-host disease. Blood 1993;81:2252-2256.
9. Dore F, Bonfigli S, Pardini S, Longinotti M: Serum interleukin-8 levels in thalassemia intermedia. Haematologica 1995;80:431-433.
10. Salsaa B, Zoumbos NC: A distinct pattern of cytokine production from blood mononuclear cells in multitransfused patients with beta-thalassemia. Clin Exp Immunol 1997;107:589-592.
11. Meliconi R, Uguccioni M, Lalli E, Nesci S, Delfini C, Paradisi O, Lucarelli G, Gasbarrini G, Facchini A: Increased serum concentrations of tumor necrosis factor in beta thalassemia: Effect of bone marrow transplantation. J Clin Pathol 1992;45:61-65.
12. Chuncharunee S, Archararit N, Hathirat P, Udomsubpayakul U, Atichartakarn V: Levels of serum interleukin-6 and tumor necrosis factor in postsplenectomized thalassemic patients. J Med Assoc Thai 1997;80:S86-S91.
13. Wanachiwanawin W, Wiener E, Siripanyaphinyo U, Chinprasertsuk S, Mawas F, Fucharoen S, Wickramasinghe SN, Pootrakul P, Visudhiphan S: Serum levels of tumor necrosis factor-alpha, interleukin-1, and interferon-gamma in β°-thalassemia/HbE and their clinical significance. J Interferon Cytokine Res 1999;19:105-111.
14. Kashiwamura S, Okamura H: IL-18 and IL-18 receptor. Nippon Rinsho 1998;56:1798-1806.
15. Klein SA, Ottmann OG, Ballas K, Dobmeyer TS, Pape M, Weidmann E, Hoelzer D, Kalina U: Quantification of human interleukin-18 mRNA expression by competitive reverse transcriptase polymerase chain reaction. Cytokine 1999;11:451-458.
16. Conti B, Park LC, Calingasan NY, Kim Y, Kim H, Bae Y, Gibson G, Joh TH: Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res 1999;67:46-52.
17. Sugama S, Kim Y, Baker H, Tinti C, Kim H, Joh TH, Conti B: Tissue-specific expression of rat IL-18 gene and response to adrenocorticotropic hormone treatment. J Immunol 2000;165:6287-6292.
18. Dinarello CA: IL-18: A Th1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
19. Prinz M, Hanisch UK: Murine microglial cells produce and respond to interleukin-18. J Neurochem 1999;72:2215-2218.
20. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor 2001;12:53-72.
21. Archararit N, Chuncharunee S, Pornvoranunt A, Atamasirikul K, Rachakom B, Atichartakarn V: Serum C-reactive level in postsplenectomized thalassemic patients. J Med Assoc Thai 2000;83:S63-S69.